He is currently Chief Scientist at Trials.ai,[2] and holds other founding positions at Natural Selection, Inc., Color Butler, Inc., and Effect Technologies, Inc., the maker of the patented EffectCheck sentiment analysis software tool.
He received an honorary doctorate for his artificial intelligence research project, Blondie24, in which a deep learning adversarial neural network evolved itself into an expert checkers player.
He served as Natural Selection, Inc.'s lead consultant for Agouron Pharmaceuticals' AGDOCK (formerly EPDOCK) protein-ligand docking software (1993-1998),[8] was principal investigator on evolutionary neural networks for breast cancer detection (1995-2000),[9] cybersecurity for a federal agency (early 2000s), and lead program manager for Natural Selection, Inc.'s machine learning system for screening food imports for the Food and Drug Administration (FDA) (2003-2008).
[10] The IEEE Computational Intelligence Society recognized Natural Selection, Inc. with its inaugural Outstanding Organization Award in 2011.
[11] Fogel also led the development of evolutionary systematic market trading algorithms that were the foundation of Natural Selection Financial, Inc. (NSFIN), a registered investment advisor company, formed in 2006.
[20] Fogel has given hundreds of public lectures at conferences, museums, and for corporate events regarding diverse aspects of AI, including the prospects of how it will be used to benefit humanity in the future.